YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
3.71 | 35.42 | -89.53% | 22.61 | -83.6% |
| P/S |
|
1.17 | 7.59 | -84.53% |
|
|
| P/BV |
|
0.931 | 3.68 | -74.74% |
|
|
| P/FCF |
|
5.53 | 55.3 | -90% |
|
|
| Ev/Ebitda |
|
12.6 | 2.91 | 333.44% |
|
|
| Ev/S |
|
1.32 | 23.72 | -94.43% |
|
|
| Ev/FCF |
|
7.72 | 63.78 | -87.9% |
|
|
| E/P |
|
0.3343 | 0.0326 | 924.5% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
6/10
|
18.65 | -11.9 | -256.7% | 22.21 | -16.03% |
| ROE |
|
28.84 | 5.19 | 455.98% |
|
|
| ROA |
|
16.18 | 3.47 | 366.27% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
31.66 | -11.49 | -375.62% |
|
|
| ROCE |
|
0 | 6.04 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
5.47 | 0.7755 | 605.31% | 4.59 | +19.25% |
| Nеt Debt/Ebitda |
|
1.34 | 0.0127 | 10397.04% |
|
|
| Debt/Ratio |
|
0.2997 | 0.1229 | 143.98% |
|
|
| Debt/Equity |
|
1.03 | 0.802 | 28.73% |
|
|
| Debt/Net Income |
|
1.92 | 1.76 | 9.08% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 5.7 | -100% | 1.63 | -100% |
| Number of years of dividend growth |
|
0 | 1.13 | -100% | ||
| DSI |
|
0.75 | 0.5838 | 28.47% |
|
|
| Average dividend growth |
|
20.5 | 3.2 | 540.13% |
|
|
| Average percentage for 5 years |
|
1.63 | 4.95 | -67.15% |
|
|
| Average percentage for payments |
|
44.55 | 23.96 | 85.92% |
|
|
| Difference from average difference in sector |
|
-5.7 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
1/10
|
1.13 | 28.69 | -96.06% | ||
| Growth impulse Ebitda in 5 years |
|
-46.13 | -40.52 | 13.85% | ||
| Growth impulse Net Income in 5 years |
|
3.85 | 94.84 | -95.94% | ||
| Growth impulse FCF in 5 years |
|
787.29 | 91.41 | 761.27% | ||
| Growth impulse EPS in 5 years |
|
-4.86 | -118.14 | -95.89% |
IP Score
5.38/10
